Dahms Bradford D.
Insider CIK 1787307 · SELB Chief Financial Officer · THRX President and CFO · JBIO Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| JBIO Jade Biosciences, Inc. | A Award deriv | 2026-02-12 | 2026-02-13 | 226,875 | — | $0 | 226,875 | SEC↗ |
| JBIO Jade Biosciences, Inc. | A Award | 2026-02-12 | 2026-02-13 | 37,813 | — | $0 | 37,813 | SEC↗ |
| JBIO Jade Biosciences, Inc. | A Award deriv | 2025-07-14 | 2025-07-14 | 526,000 | — | $0 | 526,000 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | D To issuer deriv | 2024-02-14 | 2024-02-14 | 17,500 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | D To issuer deriv | 2024-02-14 | 2024-02-14 | 332,114 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | U Tender | 2024-02-14 | 2024-02-14 | 8,150 | — | $0 | 0 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | A Award deriv | 2023-03-01 | 2023-03-02 | 17,500 | — | $0 | 17,500 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | A Award deriv | 2023-02-17 | 2023-02-21 | 105,000 | — | $0 | 105,000 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2022-11-30 | 2022-12-01 | 1,502 | $6.66 | $10.0K | 6,142 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | A Award deriv | 2022-02-18 | 2022-02-23 | 150,000 | — | $0 | 150,000 | SEC↗ |
| THRX Theseus Pharmaceuticals, I | P Buy | 2021-12-21 | 2021-12-22 | 1,970 | $10.15 | $20.0K | 1,970 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | A Award deriv | 2021-01-04 | 2021-01-06 | 230,000 | — | $0 | 230,000 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | A Award | 2021-01-04 | 2021-01-06 | 38,000 | — | $0 | 38,000 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | A Award deriv | 2020-07-01 | 2020-07-06 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | A Award deriv | 2020-01-02 | 2020-01-06 | 140,000 | — | $0 | 140,000 | SEC↗ |
| SELB SELECTA BIOSCIENCES INC | A Award deriv | 2019-09-03 | 2019-09-05 | 400,000 | — | $0 | 400,000 | SEC↗ |